Teva to return rights to experimental cancer therapy By: Philadelphia Business Journal via Business Journals December 30, 2014 at 10:30 AM EST Teva Pharmaceutical Industries Ltd. is returning to OncoGenex the rights to a cancer drug, on which the companies had previously collaborated... Read More >> Related Stocks: Teva Pharmaceutical Industries ADR